ananta medicare
ENDLESS CARE ABOUT YOUR HEALTH
#
Great Britain
News of World Medicine

Apparently the unique vaccine against HIV will soon be launched on the market

According "Remedium", Inovio company is close to creating an effective DNA vaccine Pennvax-GP against HIV infection. Clinical studies of the first phase have already been published.

Scientists tested the vaccine alone with interleukin-12 (IL-12 - an activator of cellular immunity). This combination produced a cellular immune response and increased expression of CD4 + or CD8 + cells in 71 of 76 patients. That is, the vaccine efficacy was 93%. But the humoral immune response (activation of B cells) was recorded in 94% of volunteers.

Human trials are conducted by the developers with the support of the National Institute of Allergy and Infectious Diseases USA (NIAID). By the way, NIAID organized field researches of a special immunization course against HIV infection. In South Africa 5,400 people participated in the experiment.

Two experimental vaccines - ALVAC-HIV (vector vaccine) and a two-component subunit vaccine based on the gp120 virus protein are used. Plus, the volunteers were injected with a vaccine enhancer.

Source: "Remedium"